PART 4 Transitional provision

4 Transitional provision
1 For a period of six months beginning with IP completion day, the requirements of the provisions listed in paragraph (2) do not apply to—
(a) an import of gametes or embryos into Great Britain from an EEA state or Gibraltar; or
Words in reg. 4(1)(a) substituted (31.12.2020 immediately before IP completion day) by The Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1307), regs. 1, 20(b)
(b) an export of gametes or embryos from Great Britain into an EEA state or Gibraltar,
Words in reg. 4(1)(b) substituted (31.12.2020 immediately before IP completion day) by The Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1307), regs. 1, 20(b)
provided that the Authority is satisfied that the import or, as the case may be, export, meets requirements of traceability and standards of quality and safety equivalent to those laid down in the Act.
Words in reg. 4(1) substituted (31.12.2020 immediately before IP completion day) by The Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1307), regs. 1, 20(a)
2 The provisions referred to in paragraph (1) are—
(a) subsections (4A) to (4AD) of section 24 of the Act;
(b) Schedule 3AA to the Act.
3 In this regulation—
(a) “the Act” means the Human Fertilisation and Embryology Act 1990 (as amended by these Regulations); and
(b) the terms “the Authority”, “embryo”, “gamete” and “traceability” have the same meanings as they have in the Act.
Reg. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1